10.1101/cshperspect.a025288 50 VestergaardM.BerglundN
In 2017, Neelakantan and colleagues first systematically characterized 5amino1mq during screening for selective NNMT inhibitors, with findings published in Biochemical Pharmacology - marking the official discovery and public reporting of the compound.Through structural modification of quinolinebased precursors, the team identified 5amino1mq as a small, membranepermeable molecule with the chemical formula CHN.With an extremely low IC value, it became one of the most promising selective NNMT inhibitors available at the time, with high specificity and no significant inhibition of other metabolically relevant enzymes
One liter of fluid Electrolytes and more You can also ask for a 1/2 Pure Hydration (500ml) for only $50 Surgery IV Drip $200 Allow your body to repair itself inside and out with RMCs Surgery IV drip
Furthermore, N-Acetyl Selank, a modified form, also exhibits neuroprotective qualities
His research primarily focuses on Drug Discovery and Development, Microbial Biotechnology, and Nanobiotechnology